Status:
NOT_YET_RECRUITING
Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
Lead Sponsor:
Assiut University
Conditions:
Tenofovir Disoproxil Fumarate
Renal Function Disorder
Eligibility:
All Genders
18-60 years
Brief Summary
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period
Detailed Description
Hepatitis B is a viral infection that affects 257 million people worldwide and approximately 820,000 die annually of HBV-related causes and is a leading cause of liver cirrhosis and hepato-cellular ca...
Eligibility Criteria
Inclusion
- Adult male or female patients aged 18 to 60 years.
- Diagnosed as HBV-positive.
- Long-term use of Tenofovir Disoproxil Fumarate (TDF) for more than five years.
Exclusion
- Presence of other chronic liver diseases.
- Diagnosed with Chronic Kidney Disease (CKD), regardless of etiology.
- Patients who refuse to participate in the study.
- Patients on combination therapy, including:
- Interferon and Nucleoside analogue combination therapy.
- Multiple nucleoside analogue combination therapy.
Key Trial Info
Start Date :
April 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT06896630
Start Date
April 10 2025
End Date
May 1 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Asyut, Egypt